Cover Image

Health care use and costs of adverse drug events emerging from outpatient treatment in Germany: A modelling approach

<p>Abstract</p> <p>Background</p> <p>This study's aim was to develop a first quantification of the frequency and costs of adverse drug events (ADEs) originating in ambulatory medical practice in Germany.</p> <p>Methods</p> <p>The frequencies...

Full description

Saved in:

Bibliographic Details
Main Authors:	Leidl Reiner (Author), John Jürgen (Author), Stark Renee G (Author)
Format:	Book
Published:	BMC, 2011-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Drug-related admissions and hospital-acquired adverse drug events in Germany: a longitudinal analysis from 2003 to 2007 of ICD-10-coded routine data
by: Hasford Joerg, et al.
Published: (2011)

Medication reviews by emergency department pharmacists in patients hospitalised for an adverse drug event: a cost study
by: Rehana N. Rahman, et al.
Published: (2024)

Evaluation of the Direct Costs of Managing Adverse Drug Events in all Ages and of Avoidable Adverse Drug Events in Older Adults in Japan
by: Hayato Katsuno, et al.
Published: (2021)

ADVERSE EVENT OF DRUG THERAPY (THE FIRST RESULTS OF THE STUDY ACCORDING TO THE PROFILE OUTPATIENT REGISTER)
by: Yu. V. Lukina, et al.
Published: (2016)

Italian Emergency Department Visits and Hospitalizations for Outpatients' Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study)
by: Niccolò Lombardi, et al.
Published: (2020)

Development and first assessment of a questionnaire for health care utilization and costs for cardiac patients
by: Hahmann Harry, et al.
Published: (2008)

Adverse drug reactions induced by cardiovascular drugs in outpatients
by: Gholami K, et al.
Published: (2008)

THE ROLE OF DOPING IN EMERGENCE OF ADVERSE CARDIOVASCULAR EVENTS
by: Nina Đukanović, et al.
Published: (2011)

Dermal fillers in aesthetics: an overview of adverse events and treatment approaches
by: Funt D, et al.
Published: (2013)

Costs associated with adverse events among acute patients
by: Jakob Kjellberg, et al.
Published: (2017)

Direct medical costs of adverse events in Dutch hospitals
by: Asscheman Henk, et al.
Published: (2009)

Factors associated with statin-related adverse muscular events in adult dyslipidemic outpatients
by: Paula Ferreira Castro, et al.
Published: (2018)

Adverse drug events in the prevention and treatment of COVID-19: A data mining study on the FDA adverse event reporting system
by: Qiang Guo, et al.
Published: (2022)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
by: Han N, et al.
Published: (2021)

In Silico Approach to Predict Severe Cutaneous Adverse Reactions Using the Japanese Adverse Drug Event Report Database
by: Kaori Ambe, et al.
Published: (2021)

Improving drug safety in hospitals: a retrospective study on the potential of adverse drug events coded in routine data
by: Nils Kuklik, et al.
Published: (2019)

The average cost of measles cases and adverse events following vaccination in industrialised countries
by: Kou Ulla, et al.
Published: (2002)

Emergence of psychiatric adverse events during antipsychotic treatment in AP-naïve children and adolescents
by: Marie-Line Menard, et al.
Published: (2022)

Are community-living and institutionalized dementia patients cared for differently? Evidence on service utilization and costs of care from German insurance claims data
by: Schwarzkopf Larissa, et al.
Published: (2013)

Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy
by: Hironori Fujii, et al.
Published: (2022)

Vemurafenib-Induced Toxic Epidermal Necrolysis: An Emerging Adverse Event
by: Ana Filipe Monteiro, et al.
Published: (2018)

Drug development for the treatment of onchocerciasis: Population pharmacokinetic and adverse events modeling of emodepside
by: Frauke Assmus, et al.
Published: (2022)

Drug development for the treatment of onchocerciasis: Population pharmacokinetic and adverse events modeling of emodepside.
by: Frauke Assmus, et al.
Published: (2022)

Estimating Costs Associated with Adverse Events in Patients with Advanced Lung Cancer
by: Lin CY, et al.
Published: (2024)

Vonoprazan-associated infection: an analysis of the Japanese Adverse Drug Event Report and the FDA Adverse Event Reporting System
by: Mengling Ouyang, et al.
Published: (2024)

Trends in Anti-Influenza Drug Prescription and Adverse Drug Reaction Reporting After the Lifting of Oseltamivir Prescribing Restrictions in Pediatric Outpatients: An Ecological Study Using the MDV Analyzer® And the Japanese Adverse Drug Event Report Database
by: Misaki Tokunaga, et al.
Published: (2024)

Optimisation of Approaches to Adverse Event Analysis in Bioequivalence Clinical Trials
by: A. B. Verveda, et al.
Published: (2024)

Characteristics of pediatric adverse drug reaction reports in the Japanese Adverse Drug Event Report Database
by: Aoi Noda, et al.
Published: (2020)

Health care provision for refugees in Germany - one-year evaluation of an outpatient clinic in an urban emergency accommodation
by: Hannah S. Borgschulte, et al.
Published: (2018)

Vaccination status, incidence of adverse events, and awareness of COVID-19 vaccine among outpatients undergoing chemotherapy
by: Satoshi Iwakawa, et al.
Published: (2024)

Variation in adverse drug events of opioids in the United States
by: Edward Y. Liu, et al.
Published: (2023)

Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment
by: Lina Keutzer, et al.
Published: (2023)

Analysis of economic and social costs of adverse events associated with blood transfusions in Spain
by: Borja Ribed-Sánchez, et al.
Published: (2018)

Publisher Correction: Emergence of psychiatric adverse events during antipsychotic treatment in AP-naïve children and adolescents
by: Marie-Line Menard, et al.
Published: (2023)

POSSIBLE ADVERSE EVENTS DURING IBD TREATMENT.
by: Adriana Krasteva, et al.
Published: (2011)

Estimated cost of VEGFR TKI associated adverse events in metastatic renal cell carcinoma patients
by: Jeffrey Thomas Yorio, et al.
Published: (2024)

Analysis of Adverse Events of Cholinesterase Inhibitors and NMDA Receptor Antagonists on Arrhythmias Using the Japanese Adverse Drug Event Report Database
by: Shotaro Kobayashi, et al.
Published: (2023)

Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
by: Yankun Liang, et al.
Published: (2023)

Analysis of fall-related adverse events among older adults using the Japanese Adverse Drug Event Report (JADER) database
by: Haruna Hatahira, et al.
Published: (2018)

Analyses of non-benzodiazepine-induced adverse events and prognosis in elderly patients based on the Japanese adverse drug event report database
by: Yoshihiro Noguchi, et al.
Published: (2018)